← My Government dashboard

Government Watch

Dossier Legislative introduced 21-apr-2026
Bill introduced in Congress — not yet passed by either chamber, and not law.

Drug Deal Disclosure Act

Key claim: The Drug Deal Disclosure Act (S4355, 119th Congress) was introduced and referred to the Senate Committee on Health, Education, Labor, and Pensions.

Abstract

(S4355 · 119th Congress) Latest action (2026-04-21): Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Why this matters

Drug-pricing transparency bills are a recurring vehicle for imposing disclosure requirements on manufacturers, PBMs, or intermediaries, and even bare introductions signal continued congressional attention to opaque pricing arrangements. Because the bill text and mechanism are not yet disclosed, the practical implication for patients, providers, or insurers is unknown; the finding functions primarily as a tracking marker for HELP Committee activity.

Source

Link

Briefing card

Drug Deal Disclosure Act
Stage: introduced · congress · 21-apr-2026

The Drug Deal Disclosure Act (S4355, 119th Congress) was introduced and referred to the Senate Committee on Health, Education, Labor, and Pensions.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: congress:119-s-4355:introduced

Ask about this finding

Replies are grounded in the abstract and metadata above. The model will quote directly when possible and say so if a question isn't covered.

Stages other doctrine resolution introduced proposed rule passed chamber executive action final rule enacted district opinion circuit opinion opinion

Subscribe: calendar of upcoming dates · deadlines feed · all new records

build build 392 · ea9c128-dirty · 2026-08-09